IRIS
VOGRIG, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.164
AS - Asia 1.002
EU - Europa 765
SA - Sud America 140
AF - Africa 35
OC - Oceania 2
Totale 3.108
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.146
SG - Singapore 678
IT - Italia 314
BR - Brasile 127
RU - Federazione Russa 122
CN - Cina 105
DE - Germania 81
KR - Corea 76
IE - Irlanda 72
IN - India 38
HK - Hong Kong 30
UA - Ucraina 27
FI - Finlandia 25
TG - Togo 23
AT - Austria 22
FR - Francia 21
VN - Vietnam 20
GB - Regno Unito 18
NL - Olanda 17
TR - Turchia 15
SE - Svezia 14
CA - Canada 12
BE - Belgio 6
AR - Argentina 5
CZ - Repubblica Ceca 5
JP - Giappone 5
PT - Portogallo 5
IQ - Iraq 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
EC - Ecuador 3
EG - Egitto 3
ES - Italia 3
ID - Indonesia 3
LV - Lettonia 3
MA - Marocco 3
MX - Messico 3
PK - Pakistan 3
TW - Taiwan 3
AU - Australia 2
CO - Colombia 2
CU - Cuba 2
KE - Kenya 2
LT - Lituania 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PL - Polonia 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
DZ - Algeria 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
RO - Romania 1
SC - Seychelles 1
TH - Thailandia 1
UY - Uruguay 1
Totale 3.108
Salva come PNG Salva come JPEG
Città #
Singapore 290
Fairfield 136
Boardman 104
Seoul 76
Ashburn 75
Chandler 75
Dublin 72
Trieste 71
Woodbridge 63
Beijing 56
Seattle 56
Houston 49
Wilmington 45
Cambridge 41
Milan 30
Hong Kong 29
Ogden 29
Belluno 25
Venezia 24
Lomé 23
Dearborn 22
Nuremberg 22
Munich 20
Princeton 20
Ann Arbor 19
Hyderabad 19
Dong Ket 17
Udine 17
Tavagnacco 16
Los Angeles 13
Jacksonville 12
Lappeenranta 12
Redmond 12
Frankfurt am Main 11
Helsinki 11
Düsseldorf 9
Izmir 8
London 8
San Diego 8
Rome 7
Santa Clara 7
Vienna 7
Bologna 6
Brussels 6
New York 6
Norwalk 6
Amsterdam 5
Codroipo 5
Guangzhou 5
Lauterbourg 5
New Delhi 5
Nove 5
São Paulo 5
Toronto 5
Beppu 4
Fayetteville 4
Lisbon 4
Manassas 4
Portsmouth 4
Zhengzhou 4
Bolzano 3
Brno 3
Buffalo 3
Cedar Knolls 3
Chennai 3
Chicago 3
Dallas 3
Des Moines 3
Gothenburg 3
Guarulhos 3
Istanbul 3
Mexico City 3
Phoenix 3
Pune 3
Riga 3
Riyadh 3
Rochester 3
Salt Lake City 3
Shanghai 3
Sorocaba 3
Almaty 2
Ankara 2
Augusta 2
Belém 2
Brasília 2
Cagliari 2
Cairo 2
Carapicuíba 2
Chions 2
Chisinau 2
Council Bluffs 2
Curitiba 2
Desio 2
Gdynia 2
Guayaquil 2
Havana 2
Hillsboro 2
Jundiaí 2
Juneau 2
Kunming 2
Totale 1.854
Salva come PNG Salva come JPEG
Nome #
Epidemiology of autoimmune versus infectious encephalitis 137
Tacrolimus-induced severe headache associated with diffuse leukoencephalopathy: Evidence for an immune-mediated pathogenesis 125
Peculiar EEG signatures, ictal drinking and long-term follow-up in anti-LGI1 encephalitis 117
Effect of thymectomy on refractory autoimmune status epilepticus 114
Intra-carotid self-injection of alprazolam: an unusual cause of unilateral multiembolic stroke 105
Epidemiology of paraneoplastic neurological syndromes: a population-based study 98
Seizure specificities in patients with antibody-mediated autoimmune encephalitis 94
Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario 89
Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features 85
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature 75
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 53
Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain–Barré syndrome detected in Europe in the COVID-19 era 52
Stroke in patients with SARS-CoV-2 infection: case series 49
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up 49
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 48
Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research 48
Response to Letter to the Editor on the article “Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination” 47
Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA) 45
Movement disorders in oncology: From clinical features to biomarkers 44
Efficacy of Perampanel in Refractory and Super-Refractory Status Epilepticus with Suspected Inflammatory Etiology: A Case Series 41
Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review 41
Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features 39
Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors 38
Central nervous system adverse events of immune checkpoint inhibitors 38
Reader Response: Prolonged Unconsciousness Following Severe COVID-19 38
Eating reflex epilepsy of presumed autoimmune etiology after SARS-CoV-2 vaccination 37
Back to the future: encephalitis lethargica as an autoimmune disorder? 37
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 35
Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations 34
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians 33
Sudden unexpected death in epilepsy and ictal asystole in patients with autoimmune encephalitis: a systematic review 32
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors 32
Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study 32
Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases 32
Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? 31
Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome 30
Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment 30
Stroke in patients with COVID-19: Clinical and neuroimaging characteristics 29
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience 29
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration 29
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis 28
Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features 28
Central nervous system complications associated with immune checkpoint inhibitors 28
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition 28
Adenovirus COVID-19 Vaccines and Guillain–Barré Syndrome with Facial Paralysis 28
Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis 28
Associations between HLA and autoimmune neurological diseases with autoantibodies 27
Bornavirus associated with fatal human encephalitis 27
18F-FDG PET brain findings in disease-discordant monozygotic mosaic twins with Cri du Chat (5p-) syndrome 27
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma 27
Unclear association between COVID-19 and Guillain-Barré syndrome 27
How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update 26
Paraneoplastic encephalitis: clinically based approach on diagnosis and management 26
Immune Checkpoint Inhibitor-Related Cerebellar Toxicity: Clinical Features and Comparison with Paraneoplastic Cerebellar Ataxia 26
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes 26
Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses 25
Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review 25
Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis 24
Proceedings of the “International Congress on Structural Epilepsy & Symptomatic Seizures” (STESS, Gothenburg, Sweden, 29–31 March 2023) 24
A systematic study of stereotypy in epileptic seizures versus psychogenic seizure-like events 24
Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABA B R Antibodies 22
Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis 22
Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis 21
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors 21
Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study 21
Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis 21
Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis 20
Glioblastoma as differential diagnosis of autoimmune encephalitis 20
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes 20
Immunomodulation in the acute phase of autoimmune encephalitis 20
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis 20
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients 19
Diagnosis of autoimmune encephalitides: An update 19
Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes 19
Role of LGI1 protein in synaptic transmission: From physiology to pathology 19
Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABABR and Anti-Hu Paraneoplastic Neurological Syndromes 19
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity 18
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review 18
Prognosis of status epilepticus in adults: recent advances and future directions 17
Distinguishing seizures in autoimmune limbic encephalitis from mesial temporal lobe epilepsy with hippocampal sclerosis: Clues of a temporal plus network 17
Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis 17
Neuroimmune disorders in COVID-19 17
Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies 17
Predictors and Clinical Characteristics of Relapses in LGI1-Antibody Encephalitis 16
Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies 16
Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors 16
Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis 16
Epileptic phenotypes in autoimmune encephalitis: From acute symptomatic seizures to autoimmune-associated epilepsy 16
NRAS Q61K mutated diffuse leptomeningeal melanomatosis in an adult patient with a brief review of the so-called “forme fruste” of neurocutaneous melanosis 16
Nystagmus and lower extremity hyperalgesia after colectomy 16
Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies 15
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France 15
Probable dysimmune epilepsia partialis continua manifesting as epileptic moving toes syndrome: electroclinical features of a challenging case 14
SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques 14
Post-acute anti-NMDAR encephalitis mirrors schizophrenia 14
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies 14
Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study 14
Value of Onconeural Antibodies in Checkpoint Inhibitor-Related Toxicities 13
Postencephalitic epilepsy in children and adults: Etiology matters 13
Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma 12
Totale 3.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.957
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 0 0 0 0 0 12
2020/2021255 8 22 11 20 12 24 17 23 46 14 25 33
2021/2022183 9 18 37 6 2 0 13 4 3 20 48 23
2022/2023528 20 18 3 19 176 179 4 8 31 6 17 47
2023/2024343 28 22 5 24 40 18 9 31 44 57 29 36
2024/20251.734 85 140 93 70 71 83 110 104 294 243 408 33
Totale 3.474